Theileria induces oxidative stress and HIF1[alpha] activation that are essential for host leukocyte transformation

• Published in: Oncogene Vol. 33; no. 14; p. 1809
• Main Authors: Medjkane, S, Perichon, M, Marsolier, J, Dairou, J, Weitzman, J B
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group 03.04.2014
• Subjects: Genotype & phenotype; Leukocytes; Metabolism; Molecular biology; Oxidative stress; Parasites; Tumorigenesis
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/onc.2013.134

Complex links between infection and cancer suggest that we still can learn much about tumorigenesis by studying how infectious agents hijack the host cell machinery. We studied the effects of an intracellular parasite called Theileria that infects bovine leukocytes and turns them into invasive cancer-like cells. We investigated the host cells pathways that are deregulated in infected leukocytes and might link infection and lymphoproliferative disease. We show that intracellular Theileria parasites drive a Warburg-like phenotype in infected host leukocytes, characterized by increased expression of metabolic regulators, increased glucose uptake and elevated lactate production, which were lost when the parasite was eliminated. The cohabitation of the parasites within the host cells leads to disruption of the redox balance (as measured by reduced/oxidized glutathione ratio) and elevated ROS (reactive oxygen species) levels, associated with chronic stabilization of the hypoxia-inducible factor 1 alpha (HIF1α). Inhibition of HIF1α (pharmacologically or genetically), or treatment with antioxidants, led to a marked reduction in expression of aerobic glycolytic genes and inhibited the transformed phenotype. These data show that stabilization of HIF1α, following increased ROS production, modulates host glucose metabolism and is critical for parasite-induced transformation. Our study expands knowledge about the molecular strategy used by the parasite Theileria to induce the transformed phenotypes of infected cells via reprogramming of glucose metabolism and redox signaling. [PUBLICATION ABSTRACT]